In today’s time hypertension is a disease that is taking the person of the square of each age. In the hypertension, its global report in 2025, the World Health Organization (WHO) provided India’s example for a affordable price of hypertension drugs. The World Health Organization said, “Extensive access to India’s hypertension improvement, which includes imminent the use of genetic drugs, and improves price limits on the necessary antihypertension medicine, and has improved in public health and blood pressure control rates.”
India Hypertension Control Initiative
In 2018-2019, the government’s India Hypertension Control Inflation Initiative (IHCI) ensured the reliable supply of free, good quality antibilities. It was also supported by simple, protocol-based treatment systems and strong medicines.
National Order of Pharmaceutical Pricing Authority
In addition, National Pharmaceutical Pricleity (NPPA) also determined the limitations for essential drugs including drug price control order and essential drugs. The NPPA calculated the maximum price based on average market prices, ensured that medications found to be deficient and manufacturers. Moreover, the report said it has reduced additional financial burdens on patients. It is enabled to provide reliable supply of affordable, Quality-Assigned Drugs affordable to afford the public health health system.
World Health Organization (WHO) study
“The study shows that when high blood pressure drugs are purchased and distributed through the public sector channels or democratic drug stores, which can be less than 80 percent over the public. The report states that before they were implemented to these reforms, hypertension control rates were lower in India. About 14 percent of adults have controlled High BP.
According to the statistics of Punjab and Maharashtra
Who said, “Punjab and Maharashtra’s recent programs of Punjab and Maharashtra was discovered by the patients with a 70-81 percent blood pressure control rate during follow-up, the average sylody of the blood pressure was reduced 15-16 m hg.”
According to Global Health Organization, “This improvements show that the public investment in affordable and accessible antihypertension medications also reduces the public investment.” Surprisingly, the World Health Organization reports that 1.4 billion people were suffering from high blood pressure, but also controlled it in only one medicine or other means.
National Hypertension control rates in 99 countries are less than 20%
Analysis of 195 countries and territories indicate that in 99, National Hypertension control rates are less than 20%. Out of 28% of low-income countries reported that all hypertension drugs recommended by the World Health Organization is usually available in pharmacies or primary health centers.